Trademark Overview
On Monday, February 17, 2025, a trademark application was filed for ROCKFISH BIO with the United States Patent and Trademark Office. The USPTO has given the ROCKFISH BIO trademark a serial number of 79421383. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, April 10, 2025. This trademark is owned by Rockfish Bio AG. The ROCKFISH BIO trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Reagents and assays for medical or veterinary use; pharmaceuticals; pharmaceuticals for the treatment and prevention of chronic diseases; pharmaceuticals for the treatment and prevention of age-related disorders and diseases and neurodegenerative disorders and diseases; pharmaceuticals for healthy ageing; pharmaceuticals for the treatment and prevention of disorders and diseases linked to senescent cell accumulation.
Assays and reagents for scientific and research use; diagnostic reagents for scientific use; senolytics.
Human healthcare services; medical and healthcare services; medical testing for diagnostic or treatment purposes; medical analysis services relating to the treatment of patients; medical testing services relating to the diagnoses and treatment of diseases; consultancy and information services relating to medical, pharmaceutical and biopharmaceutical products; provision of medical treatment for prophylaxis or therapy; medical and healthcare services in the field of personalized medicine; services of personalized medical treatment for prevention of chronic diseases, age-related disorders and diseases and neurodegenerative disorders and diseases; information consultancy and advisory services in relation to the aforesaid.
Scientific research and development; scientific research and development in the fields of senolytics, age-related disorders and diseases and neurodegenerative disorders and diseases therapies; services related to scientific research, development and production of pharmaceutical and biopharmaceutical agents and preparations; services in the field of research, development and production of medical, pharmaceutical and biopharmaceutical products; medical- and pharmacological research services; pharmaceutical, biopharmaceutical drug development services; drug discovery services; providing medical and scientific research information in the field of clinical trials.
